FDA Supports Use of Anti-diarrheal Medications with Nerlynx
News
The U.S. label of Nerlynx (neratinib), a treatment for early stage HER2-positive breast cancer, now includes information on the use of two anti-diarrheal medications to prevent severe side effects of the therapy. ... Read more